March 1, 2021

New cholesterol drug’s high price may not be worth it: Study

Pin It

From Newsmax Despite being slashed by half in recent months, the price tag for advanced cholesterol-fighting drugs is still too high to make them cost-effective, a new analysis has concluded. In March, the manufacturer of alirocumab (Praluent) announced that it would cut the cost of the medication from $14,000 a year to $7,000. But the […]